Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy

▤ Summary

Laprophan completed its acquisition of a controlling stake in Rivopharm, a Swiss pharmaceutical company with manufacturing and development capabilities. The deal expands Laprophan’s footprint in Europe and supports its broader international growth strategy across Europe, Africa, the Middle East, and other markets. Rivopharm brings a manufacturing site, dossier development expertise, complex formulation capabilities, and commercial reach in more than 30 countries. The companies have already started integration work to align operations and execute joint strategic priorities. The transaction also strengthens Laprophan’s B2B pharmaceutical and out-licensing activities.

▦ Linked Companies